Hereditary angioedema (HAE) is a rare but potentially life‐threatening disorder, most often caused by deficiency or dysfunction of C1 esterase inhibitor (C1‐INH), leading to unregulated activation of the kallikrein-kinin system and excessive production of bradykinin. This evidence concerns the gene KLK4 and hereditary angioedema.